January 19, 2011 – TechniScan, a medical device company engaged in the development and commercialization of an automated 3-D breast ultrasound imaging system, said this week it signed a product development agreement with Womens3D Inc. In the deal, worth a minimum of $1.5 million, TechniScan and Womens3D will co-develop technology specifically for Womens3D's proposed target market that is directed toward women's health practices. Under the terms of the agreement, Womens3D acquired a prototype of the TechniScan WBU system for $250,000 and contemplates contributing at least $1.25 million more to support development of a specialized whole breast ultrasound imaging system based on the TechniScan Warm Bath Ultrasound (WBU) product now in clinical testing. In addition, TechniScan will supply technical support of the product and customization of the imaging network applications that will be used in part to store and transmit the image files. "As a part of the development agreement, we purchased a prototype WBU system for evaluation, and we are now very excited to be working with TechniScan and welcome their expertise as we address the needs of the developing markets in women's health," said Scott Sanders, Womens3D CEO. Womens3D's Chief Science Officer Mark Lenox, Ph.D., formerly part of the engineering team that performed the research and early development and commercialization of positron emission tomography (PET) in nuclear medical imaging, conducted the technical evaluation of TechniScan's WBU system. TechniScan's Warm Bath Ultrasound (WBU) system is designed to capture three-dimensional images of the breast as a woman lies prone on a table while proprietary ultrasound technology in a warm water tank images the breast anatomy. This new method of imaging produces diagnostic information that is not available with traditional hand-held ultrasound or whole breast ultrasound systems presently on the market. "TechniScan is excited to be working with Womens3D on this development program, which potentially will open new markets for our equipment and add a valuable partner to our development efforts. Over the next one to two years we expect to complete the development of an ultrasound system for Womens3D based on our technology," said Dave Robinson, TechniScan CEO. TechniScan's WBU imaging device is limited by U.S. law to investigational use. For more information: www.tsni.com, www.Womens3D.com
March 06, 2026 
